Spar spends EUR 2.5 mn on them.
It does not plan expansion, either.
HUF remains in hybernation.
Change coming up in mid-2019, as well.
Earnings do rise, but prices climb higher too.
U.S. FDA rejects application by Allergan.
Plaza ban is now stricter.
Turkey is mentioned too.
No surprise there.
Average yield remains a tad over 0%.
Weekly macro calendar is almost empty.
Nine out of ten farms face skills shortage.